Treatment of complicated hypertension.
D000208:Acute Disease; D002543:Cerebral Hemorrhage / Q000209:etiology; D002561:Cerebrovascular Disorders / Q000209:etiology; D002908:Chronic Disease; D003327:Coronary Disease / Q000209:etiology; D004232:Diuretics / Q000627:therapeutic use; D004976:Ethacrynic Acid / Q000627:therapeutic use; D005665:Furosemide / Q000627:therapeutic use; D006333:Heart Failure / Q000209:etiology; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy*; D002542:Intracranial Embolism and Thrombosis / Q000209:etiology; D007674:Kidney Diseases / Q000209:etiology; D009599:Nitroprusside / Q000627:therapeutic use; D011654:Pulmonary Edema / Q000209:etiology; D013565:Sympatholytics / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use
D004232:Diuretics; D013565:Sympatholytics; D014665:Vasodilator Agents; D009599:Nitroprusside; D005665:Furosemide; D004976:Ethacrynic Acid